Safety Follow-up Through 180 Days of Treatment with Remestemcel-L in Study MSB-GVHD001 in Pediatric Patients who have Failed to Respond to Steroid Treatment for Acute GVHD

Administered By

Awarded By

Contributors

Start/End

  • October 19, 2015 - October 18, 2018